文献速递主动脉疾病

破裂腹主动脉瘤修复中REBOA的围手术期结局与安全性:倾向匹配队列研究

Perioperative Outcomes and Safety of Resuscitative Endovascular Balloon Occlusion of the Aorta in Ruptured Abdominal Aortic Aneurysm Repair: A Propensity-Matched Cohort Study.
PubMed 文献 · J Endovasc Ther · 2026-03-17

该回顾性研究分析107例破裂腹主动脉瘤修复患者,比较REBOA与非REBOA的围手术期结局,并行倾向评分匹配(1:2)后纳入22例REBOA和44例非REBOA患者。REBOA技术成功率100%,30天死亡率无显著差异(13.6% vs 22.7%,p=0.555),但REBOA组主要不良心血管事件(MACE)发生率显著降低(4.5% vs 20.5%,p=0.043),术中舒张压更高(平均差+6.7 mm Hg,p=0.031)。

要点

  • REBOA在破裂腹主动脉瘤修复中技术成功率高且安全,仅1例穿刺点血肿。
  • REBOA未显著改善30天死亡率,但MACE发生率显著降低。
  • REBOA组术中舒张压更高,血流动力学更稳定。

核心结论

  • REBOA在破裂腹主动脉瘤修复中技术成功率高、安全性好,可改善术中血流动力学稳定性并降低MACE发生率,但未显著影响死亡率或生存率。

研究设计与样本

  • 回顾性分析2013-2022年连续107例破裂腹主动脉瘤患者,按手术方式(开放手术 vs 腔内修复)和REBOA使用分层。
  • 基于术前休克、合并症和动脉瘤形态进行倾向评分匹配(1:2),最终纳入22例REBOA和44例非REBOA患者。

主要发现

  • REBOA用于22例患者(开放手术10/45 [22.2%],EVAR 12/62 [19.4%]),技术成功率100%。
  • 仅发生1例Clavien-Dindo I级穿刺点血肿(4.5%),未见主动脉损伤、远端栓塞、肢体缺血或球囊失败。
  • 匹配后30天死亡率无显著差异(13.6% vs 22.7%,p=0.555)。
  • REBOA组MACE发生率显著降低(4.5% vs 20.5%,p=0.043),术中舒张压更高(平均差+6.7 mm Hg,p=0.031)。
  • 失血量、ICU停留时间和费用两组相当,长期生存相似(log-rank p=0.375)。

关键数值与推荐

  • REBOA组30天死亡率为13.6%,非REBOA组为22.7%(p=0.555)。
  • REBOA组MACE发生率为4.5%,非REBOA组为20.5%(p=0.043)。
  • REBOA组术中舒张压平均高6.7 mm Hg(p=0.031)。
  • REBOA技术成功率为100%,穿刺点血肿发生率为4.5%。

临床怎么用

  • 对于血流动力学不稳定的破裂腹主动脉瘤患者,尤其是难治性休克或解剖条件困难者,可考虑使用REBOA。
  • REBOA可能通过增加冠状动脉灌注发挥复苏和心脏保护作用,但需更大规模前瞻性试验确认MACE获益。

局限性

  • REBOA-开放手术与REBOA-EVAR亚组比较样本量小,统计效能不足,结论不确定。
  • 需更大规模前瞻性试验验证MACE减少的发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare perioperative outcomes between resuscitative endovascular balloon occlusion of the aorta (REBOA) and non-REBOA management in ruptured abdominal aortic aneurysm (rAAA) repair, and to perform an exploratory comparison of REBOA outcomes between open surgical repair (OSR) and endovascular aortic repair (EVAR). METHODS: A retrospective analysis was conducted of 107 consecutive rAAA patients (2013-2022), stratified by surgical approach (OSR vs EVAR) and REBOA utilization. Propensity score matching (1:2) was performed based on preoperative shock, comorbidities, and aneurysm morphology, yielding 22 REBOA and 44 non-REBOA patients. Outcomes were compared statistically. RESULTS: Resuscitative endovascular balloon occlusion of the aorta was utilized in 22 patients (10/45 [22.2%] OSR and 12/62 [19.4%] EVAR), with a 100% technical success rate. One Clavien-Dindo grade I access site hematoma occurred (4.5%). No instances of aortic injury, distal embolization, limb ischemia, or balloon failure were observed. After matching, 30-day mortality did not differ significantly (13.6% vs 22.7%, p=0.555). Resuscitative endovascular balloon occlusion of the aorta was associated with a significantly reduced rate of major adverse cardiovascular event (MACE) (4.5% vs 20.5%, p=0.043) and a higher intraoperative diastolic blood pressure (BP) (mean difference+6.7 mm Hg, p=0.031). Blood loss, intensive care unit stay length, and costs were comparable between groups. Long-term survival was similar (log-rank p=0.375). In an exploratory analysis, outcomes between REBOA-OSR (n=10) and REBOA-EVAR (n=12) subgroups showed no significant differences in mortality or MACE, although this analysis was underpowered. CONCLUSIONS: Resuscitative endovascular balloon occlusion of the aorta demonstrated high technical success and an excellent safety profile in rAAA repair. Its use was associated with improved intraoperative hemodynamic stability (higher diastolic BP) and a reduced rate of MACE, although it did not significantly impact mortality or survival. Larger, prospective trials are warranted to confirm the observed reduction in MACE. The comparative outcomes of REBOA in OSR versus EVAR settings remain inconclusive due to the limited sample size.Clinical ImpactThis study demonstrates that resuscitative endovascular balloon occlusion of the aorta (REBOA) in ruptured abdominal aortic aneurysm (rAAA) repair is safe and feasible, and is associated with improved intraoperative hemodynamics and reduced major adverse cardiovascular events. For clinicians, these findings support its use for unstable rAAA patients, particularly those with refractory shock or challenging anatomy. Resuscitative endovascular balloon occlusion of the aorta may serve as both a resuscitative and a cardioprotective strategy by augmenting coronary perfusion. The innovation lies in validating its contemporary safety and proposing a mechanism for cardiac benefits, potentially changing risk-benefit assessments in emergency aortic surgery.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Zhang L, Xia D, Li R, et al. Perioperative Outcomes and Safety of Resuscitative Endovascular Balloon Occlusion of the Aorta in Ruptured Abdominal Aortic Aneurysm Repair: A Propensity-Matched Cohort Study. J Endovasc Ther. 2026. PMID: 41841616. doi:10.1177/15266028261434102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。